Company Intelligence
Ultromics
Ultromics provides enterprise-grade artificial intelligence solutions, delivering specialized Ultromics Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Oxford, United Kingdom
- Website
- ultromics.com
- Founded
- 2017
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Ultromics is a Healthcare AI company based in Oxford, United Kingdom, founded in 2017.
Oxford echocardiography AI company with FDA-cleared EchoGo platform for heart failure and cardiac amyloidosis detection from standard ultrasound.
Verified founder profile on Brel: Ross Upton.
What it does
Through the deployment of Ultromics Platform, Ultromics provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
Ultromics Platform
Why It Matters
Ultromics provides enterprise-grade artificial intelligence solutions, delivering specialized Ultromics Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Funding
Verified funding disclosures on file for this company.
- July 31, 2025: Ultromics raised $55 million Series C co-led by L&G, Allegis Capital, and Lightrock.
Products
Products and platforms connected to this company.
-
Ultromics — Medical Imaging
Explore Ultromics — Medical Imaging by Ultromics. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Ultromics
Industry
Industries served
- Medical Imaging
Products
Technologies
Capabilities
EchoGo applies deep learning to standard echocardiogram DICOM studies, generating real-time probability scores for HFpEF and cardiac amyloidosis rather than automating measurements…
Features
EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into…
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does Ultromics do?
Ultromics specializes in artificial intelligence, developing Ultromics Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Ultromics based and when was it founded?
Ultromics is based in United Kingdom and was founded in 2017.
What are the main products offered by Ultromics?
The flagship platform from Ultromics is Ultromics Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Ultromics?
Ultromics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.